Skip to content

Validation of a visual analogue symptom score - the LRTI (lower respiratory tract infections)-VAS- in non-CF bronchiectasis

Validation of a visual analogue symptom score - the LRTI (lower respiratory tract infections)-VAS- in non-CF bronchiectasis - VAS-validation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34926
Enrollment
50
Registered
2010-04-20
Start date
2010-05-03
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irriversible dilatation of the large en medium-size airways.

Interventions

None listed

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Part 1: - Bronchiectasis confirmed by HRCT - Spirometry (FEV1, FVC)

Exclusion criteria

Exclusion criteria: - Illiteracy or psychological incapacity to complete a standard questionnaire. - No informed consent - Cystic fibrosis

Design outcomes

Primary

MeasureTime frame
The results of the 4 questionnaires, correlated to lung function and arterial ogygen saturation. Validity, responsiveness en stability of the VAS-score.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)